{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:08:00Z","timestamp":1767006480231},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ijid.2016.04.008","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T00:30:50Z","timestamp":1460248250000},"page":"23-28","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Middle East respiratory syndrome vaccines"],"prefix":"10.1016","volume":"47","author":[{"given":"Stanley","family":"Perlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2016.04.008_bib0405","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0410","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.04.008_bib0415","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3201\/eid2008.140596","article-title":"Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013","volume":"20","author":"Corman","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2016.04.008_bib0420","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3201\/eid2007.140571","article-title":"MERS coronavirus in dromedary camel herd, Saudi Arabia","volume":"20","author":"Hemida","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2016.04.008_bib0425","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.3201\/eid2012.141026","article-title":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa 1983-1997","volume":"20","author":"M\u00fcller","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2016.04.008_bib0430","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","article-title":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia","volume":"351","author":"Sabir","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijid.2016.04.008_bib0435","first-page":"825","article-title":"Coronaviridae","volume":"Vol. 1","author":"Masters","year":"2013"},{"key":"10.1016\/j.ijid.2016.04.008_bib0440","doi-asserted-by":"crossref","first-page":"e01062-13","DOI":"10.1128\/mBio.01062-13","article-title":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus","volume":"5","author":"Cotten","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.ijid.2016.04.008_bib0445","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/cid\/ciu359","article-title":"Hospital-associated outbreak of middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description","volume":"59","author":"Al-Abdallat","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2016.04.008_bib0450","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1408636","article-title":"2014 MERS-CoV outbreak in Jeddah\u2014a link to health care facilities","volume":"372","author":"Oboho","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0455","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrmicro1343","article-title":"Coronavirus infection of the central nervous system: host-virus stand-off","volume":"4","author":"Bergmann","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0460","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV\u2014a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0465","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/JVI.02041-07","article-title":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium","volume":"82","author":"Sheahan","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0470","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1128\/JVI.64.9.4589-4592.1990","article-title":"Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells","volume":"64","author":"Williamson","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0475","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-5728(90)90050-W","article-title":"Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated","volume":"30","author":"Wang","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0480","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.165.4.2278","article-title":"CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination","volume":"165","author":"Wu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0485","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.4049\/jimmunol.168.3.1204","article-title":"Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells","volume":"168","author":"Ramakrishna","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0490","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1017\/S0022172400022294","article-title":"Coronavirus antibody tires in sera of healthy adults and experimentally infected volunteers","volume":"70","author":"Bradburne","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.ijid.2016.04.008_bib0495","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2016.04.008_bib0500","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0505","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0510","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00705-009-0409-6","article-title":"Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection","volume":"154","author":"Fan","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0515","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.virol.2006.03.036","article-title":"Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients","volume":"351","author":"Peng","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.04.008_bib0520","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0525","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/03079450310001621198","article-title":"Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus","volume":"32","author":"Cavanagh","year":"2003","journal-title":"Avian Pathol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0530","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0065-3519(99)80033-0","article-title":"Enteric viral infections of pigs and strategies for induction of mucosal immunity","volume":"41","author":"Saif","year":"1999","journal-title":"Adv Vet Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0535","first-page":"157","article-title":"Transmissible gastroenteritis virus infection: a vanishing specter","volume":"113","author":"Schwegmann-Wessels","year":"2006","journal-title":"Dtsch Tierarztl Wochenschr"},{"key":"10.1016\/j.ijid.2016.04.008_bib0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tvjl.2014.04.017","article-title":"An update on feline infectious peritonitis: virology and immunopathogenesis","volume":"201","author":"Pedersen","year":"2014","journal-title":"Vet J"},{"key":"10.1016\/j.ijid.2016.04.008_bib0545","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/JVI.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0550","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0555","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0560","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0565","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0570","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0575","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2016.04.008_bib0580","doi-asserted-by":"crossref","first-page":"234ra259","DOI":"10.1126\/scitranslmed.3008140","article-title":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein","volume":"6","author":"Jiang","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0585","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0590","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies","volume":"88","author":"Ying","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0595","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0600","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0605","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0610","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1128\/JVI.00446-15","article-title":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection","volume":"89","author":"Zhao","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0615","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a phase I clinical trial","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2016.04.008_bib0620","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2016.04.008_bib0625","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijid.2016.04.008_bib0630","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijid.2016.04.008_bib0635","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0640","doi-asserted-by":"crossref","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2016.04.008_bib0645","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.00385-06","article-title":"Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis","volume":"80","author":"Almazan","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0650","doi-asserted-by":"crossref","first-page":"12995","DOI":"10.1073\/pnas.1735582100","article-title":"Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus","volume":"100","author":"Yount","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0655","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1128\/JVI.01467-06","article-title":"A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo","volume":"81","author":"DeDiego","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0660","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1128\/JVI.00304-08","article-title":"A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters","volume":"82","author":"Lamirande","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0665","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virol.2010.01.004","article-title":"Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease","volume":"399","author":"Netland","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.04.008_bib0670","doi-asserted-by":"crossref","first-page":"e1005215","DOI":"10.1371\/journal.ppat.1005215","article-title":"Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine","volume":"11","author":"Jimenez-Guardeno","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2016.04.008_bib0675","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/nm.2972","article-title":"A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease","volume":"18","author":"Graham","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0680","doi-asserted-by":"crossref","first-page":"12546","DOI":"10.1073\/pnas.0605438103","article-title":"Rewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genome","volume":"103","author":"Yount","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0685","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1371\/journal.ppat.0030109","article-title":"Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines","volume":"3","author":"Zust","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2016.04.008_bib0690","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2016.04.008_bib0695","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1099\/vir.0.2008\/001891-0","article-title":"Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines","volume":"89","author":"See","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0700","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2007.04.065","article-title":"Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques","volume":"25","author":"Kobinger","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2016.04.008_bib0705","doi-asserted-by":"crossref","first-page":"948","DOI":"10.4049\/jimmunol.180.2.948","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0710","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(04)16501-X","article-title":"Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS","volume":"363","author":"Bukreyev","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2016.04.008_bib0715","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0720","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.virol.2014.01.002","article-title":"Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein","volume":"452\u2013453","author":"Escriou","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.04.008_bib0725","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.vaccine.2008.01.057","article-title":"Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses","volume":"26","author":"Liniger","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2016.04.008_bib0730","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2008.03.002","article-title":"SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector","volume":"376","author":"Kapadia","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.04.008_bib0735","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0740","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0745","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","article-title":"Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity","volume":"393","author":"Du","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.ijid.2016.04.008_bib0750","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2016.04.008_bib0755","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0760","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform","volume":"89","author":"Malczyk","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2016.04.008_bib0765","doi-asserted-by":"crossref","first-page":"301ra132","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0770","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijid.2016.04.008_bib0775","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2014.11.013","article-title":"Receptor-binding domain-based subunit vaccines against MERS-CoV","volume":"202","author":"Zhang","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.ijid.2016.04.008_bib0780","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels","volume":"351","author":"Haagmans","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijid.2016.04.008_bib0785","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2016.04.008_bib0790","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2016.04.008_bib0795","doi-asserted-by":"crossref","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2016.04.008_bib0800","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.virol.2015.07.013","article-title":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3\/2012 or MERS-CoV EMC\/2012 isolates does not result in lethal disease","volume":"485","author":"Johnson","year":"2015","journal-title":"Virology"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216310219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971216310219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T13:46:38Z","timestamp":1655473598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971216310219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":80,"alternative-id":["S1201971216310219"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2016.04.008","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Middle East respiratory syndrome vaccines","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2016.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}